A phase 3 clinical trial determined if adding aprepitant to antiemetic prophylaxis would further reduce the risks of chemotherapy-induced nausea and vomiting for women receiving chemotherapy for GI cancer.
A review of the factors that contribute to the occurrence of extravasation in patients receiving IV treatments is presented with management steps.
Researchers explored the effectiveness of olanzapine with granisetron and dexamethasone in patients with thoracic malignancies.
In this prospective study, researchers sought to determine the effect of mean muscle mass on clinical outcomes and survival among hospitalized patients with advanced cancer.
A randomized trial sought to determine the effectiveness of electroacupuncture and auricular acupuncture in managing musculoskeletal pain in cancer survivors.
Results of a phase 3 randomized trial of the eRAPID online system for patients to self-report symptoms while undergoing cancer therapy are presented.
Investigators sought to determine the efficacy of using electronic PRO systems to monitor and manage symptoms in patients with advanced and metastatic cancer.
Using a self-report questionnaire, investigators sought to distinct insomnia syndrome distinct from sleep disturbance in patients with cancer.
Retrospective analysis demonstrates the value in distinguishing between these conditions to salvage chemotherapy and/or targeted therapy dose in patients with cancer.
The efficacy and safety of direct oral anticoagulants and vitamin K antagonists in the treatment of ATEs/VTEs in patients with MPNs was compared.
